Johnson & Johnson (JNJ) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow...
We also talk with Sean Milliken, managing director of The Motley Fool Foundation’s ImpactFool (IF) Fund.
These stocks could be ideal for investors in their golden years.
Income-seeking investors can find plenty of opportunities in any market environment.
All four of these stocks are trading at very intriguing valuations.
The U.S. Supreme Court on Thursday blocked Purdue Pharma's bankruptcy settlement, which would have shielded the Sackler family from lawsuits related to their role in the opioid crisis. The decision reversed...
These two dividend growth stocks can level up your portfolio.
Johnson & Johnson's business is growing at a decent rate, but there's still a fair bit of risk surrounding the company.
J&J is the textbook blue chip stock -- but it's not for everyone.
While Kenvue's shares have notably lagged behind the Dow Jones in the past year, analysts hold a moderately bullish outlook on the stock.